Singapore Markets close in 7 hrs 17 mins

AnPac Bio-Medical Science Co., Ltd. (ANPC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
5.79-0.52 (-8.19%)
At close: 03:39PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.63
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 311.99
52-week low 32.60
50-day moving average 38.28
200-day moving average 35.49

Share statistics

Avg vol (3-month) 327.72k
Avg vol (10-day) 321.96k
Shares outstanding 52.04M
Implied shares outstanding 6N/A
Float 81.9M
% held by insiders 17.22%
% held by institutions 11.05%
Shares short (30 Jan 2023) 460.59k
Short ratio (30 Jan 2023) 41.28
Short % of float (30 Jan 2023) 4N/A
Short % of shares outstanding (30 Jan 2023) 42.97%
Shares short (prior month 29 Dec 2022) 4125.74k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 0.00%
Operating margin (ttm)-491.45%

Management effectiveness

Return on assets (ttm)-69.81%
Return on equity (ttm)-2,985.73%

Income statement

Revenue (ttm)15.91M
Revenue per share (ttm)12.60
Quarterly revenue growth (yoy)44.50%
Gross profit (ttm)12.25M
EBITDA -73.71M
Net income avi to common (ttm)-101.1M
Diluted EPS (ttm)-1.20
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.58M
Total cash per share (mrq)3.67
Total debt (mrq)8.82M
Total debt/equity (mrq)592.54
Current ratio (mrq)0.66
Book value per share (mrq)-0.02

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A